Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Anemia

Free Subscription 26.01.2026 1 Am J Hematol 1 Am J Kidney Dis 6 Ann Hematol 4 Br J Haematol 1 Cancer 1 Exp Hematol 2 Haematologica 1 Leukemia 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. LANIKOVA L, Hrckulak D, Zimolova V, Lorenzo FR, et al
   Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation.
   Am J Hematol. 2026 Jan 23. doi: 10.1002/ajh.70208.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

2. HAASE VH, Costa NA, Koury MJ
   Navigating Anemia Therapy in CKD: The Role of Hypoxia-Inducible Factor Activators.
   Am J Kidney Dis. 2026 Jan 19:S0272-6386(26)00008.
   PubMed         Abstract available
   
   

   
   Ann Hematol

3. GEORGE B, Ross CR, Damodar S, Seth T, et al
   A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte globulin (eATG).
   Ann Hematol. 2026;105:52.
   PubMed         Abstract available
   
   
4. HALKES CJM, Koster EAS, Bogers EJM, Heubel-Moenen FCJI, et al
   Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry.
   Ann Hematol. 2026;105:51.
   PubMed         Abstract available
   
   
5. IORI AP, De Vivo A, Di Bona E, Caocci G, et al
   Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study.
   Ann Hematol. 2026;105:50.
   PubMed         Abstract available
   
   
6. ALLARD PN, Kulozik AE, Kunz JB
   Case series: a rare dominant form of beta-thalassemia successfully treated by luspatercept.
   Ann Hematol. 2026;105:45.
   PubMed         Abstract available
   
   
7. HU K, Cheng Y, Xiao G, Shen X, et al
   Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia.
   Ann Hematol. 2026;105:36.
   PubMed         Abstract available
   
   
8. BISIOU S, Lobbes H, Palassin P, Allouchery M, et al
   Immune checkpoint inhibitor-induced pure red cell aplasia: a nationwide retrospective case series and literature review.
   Ann Hematol. 2026;105:38.
   PubMed         Abstract available
   
   

   
   Br J Haematol

9. ISHIYAMA K, Yamazaki M, Maruyama H, Hosono N, et al
   Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.
   Br J Haematol. 2026;208:295-303.
   PubMed         Abstract available
   
   
10. RECH JS, Santin A, Lionnet F, Mattioni S, et al
    Emergency department utilization patterns in adults living with sickle cell disease.
    Br J Haematol. 2026;208:285-294.
    PubMed         Abstract available
    
    
11. MUSALLAM KM, Taher AT, Porter JB, Kattamis A, et al
    Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent beta-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial.
    Br J Haematol. 2026;208:348-352.
    PubMed         Abstract available
    
    
12. STINNETT PZ, Ogg RJ, Helton K, Wang W, et al
    Cerebral blood flow trajectories in paediatric sickle cell anaemia by age, region, and treatment associations.
    Br J Haematol. 2026;208:367-372.
    PubMed         Abstract available
    
    

    
    Cancer

13. BUCHRITS S, Rozental A, Korngold N, Algor O, et al
    Glucose-6-phosphate dehydrogenase deficiency is associated with improved survival in patients with acute myeloid leukemia treated with venetoclax and azacitidine.
    Cancer. 2026;132:e70265.
    PubMed         Abstract available
    
    

    
    Exp Hematol

14. ALEXOPOULOS A, Nahiyan R, Swaminathan T, Roddur S, et al
    Vitamin B6 deficiency anemia resembles IDA but does not activate intestinal HIF2?.
    Exp Hematol. 2026 Jan 18:105367. doi: 10.1016/j.exphem.2025.105367.
    PubMed         Abstract available
    
    

    
    Haematologica

15. FATTIZZO B, Abbatista M, Cecchi N, Novembrino C, et al
    Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis.
    Haematologica. 2026 Jan 22. doi: 10.3324/haematol.2025.288981.
    PubMed         Abstract available
    
    
16. KANEZAKI R, Toki T, Okuse R, Kobayashi A, et al
    Functional impact of a deep intronic variant in the RPS19 gene detected in a case of Diamond-Blackfan anemia syndrome.
    Haematologica. 2026 Jan 22. doi: 10.3324/haematol.2025.300131.
    PubMed         Abstract available
    
    

    
    Leukemia

17. BAROSI G, De Silvestri A, Gale RP, Rosti V, et al
    Prognostic value of anemia plus thrombocytopenia in primary myelofibrosis.
    Leukemia. 2026 Jan 22. doi: 10.1038/s41375-026-02860.
    PubMed        
    
    

    
    PLoS One

18. AYON SS, Al Mamun A, Hossain ME, Alamro W, et al
    Explainable AI framework for improved Thalassemia mental health classification and feature selection.
    PLoS One. 2026;21:e0341168.
    PubMed         Abstract available
    
    
19. BENTLEY AR, Ntabadde K, Kabeza CB, Ekoru K, et al
    HbA1c underperforms in identifying abnormal glucose tolerance in the presence of G6PD deficiency: Insight from the Africans in America study.
    PLoS One. 2026;21:e0334634.
    PubMed         Abstract available
    
    
20. FLORES-MEJIA LA, Siliceo P, Figueroa UJ, De la Cruz AA, et al
    Prediction of myeloid malignant cells in Fanconi anemia using machine learning.
    PLoS One. 2026;21:e0340578.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.